About this trial
Establish a cohort of diabetic kidney disease(DKD) patients with intensive weight loss treatment to evaluate the impact of intensive weight loss treatment on the renal prognosis of DKD and construct a prediction model for the improvement of renal outcomes after weight loss.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 to 65 years old;
BMI>25Kg/m2 or abdominal obesity (i.e. waist circumference>90cm for men and>85cm for women);
eGFR<30ml/min/1.73m2 or urinary microalbumin≥300mg/g, eGFR<60ml/min/1.73m2.
Disqualifiers
Patients who are taking glucocorticoids;
Combined with tumors; ③Combined with autoimmune diseases; ④Serum albumin<25g/L.
Trial population
Obese patients with DKD treated with intensive weight loss or traditional treatment
Trial design
Cohort
Other
Treatments tested in this trial
Bariatric surgery
Procedure/SurgeryLaparoscopic sleeve gastrectomy or laparoscopic gastric bypass based on β-cell function
Non-surgical therapy
Other interventionDiet management,exercise,metformin,GLP-1 receptor agonists and other drugs which can lose weight.
Treatment groups
Trial outcomes
Primary outcomes
Total weight loss
Secondary outcomes
Serum creatinine
Glomerular filtration rate
Fasting blood glucose
Average blood glucose from continuous glucose monitoring
Sponsors and contacts
Click on the lead sponsor to view all of their trials.